GlassScriptPhysician profile
Berna B Moore
NPI 1316024375
$4,793.17
in general payments reported to CMS, 2019-2025
19 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $1,029 · 2024: $2,123 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,481 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,480.57 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $837.65 | 2023-2025 | |
| Incyte Corporation | $687.54 | 2022-2025 | Opzelura |
| Janssen Biotech, INC. | $468.69 | 2023-2025 | Tremfya |
| Abbvie INC. | $398.19 | 2023-2025 | |
| Leo Pharma INC. | $389.79 | 2024-2025 | Adbry, Anzupgo, Spevigo |
| E.R. Squibb & Sons, L.L.C. | $341.70 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $292.65 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $263.09 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $243.19 | 2023-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $190.47 | 2023-2025 | Ilumya, Winlevi |
| Arcutis Biotherapeutics, INC. | $152.79 | 2023-2025 | Zoryve |
| Pfizer INC. | $118.10 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.75 | 2024-2025 | Spevigo |
| Dermavant Sciences, INC. | $99.43 | 2023-2024 | Vtama |
| Amgen INC. | $86.14 | 2023-2024 | Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $69.17 | 2024-2025 | Aklief |
| Acera Surgical, INC. | $16.91 | 2025 | Restrata Wound Matrix |
| Organogenesis INC. | $16.55 | 2024 | |
| Verrica Pharmaceuticals INC. | $15.37 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berna Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.